Market Closed -
OTC Markets
01:27:33 23/05/2024 am IST
5-day change
1st Jan Change
0.0902
USD
+9.47%
+6.12%
-57.05%
Sonendo Provides Revenue Guidance for the Full Year of 2022
March 24, 2022 at 01:42 am IST
The Sonendo, Inc. expects full year 2022 total revenue to be in the range of $40 million to $43 million.
Transcript : Sonendo, Inc., Q1 2024 Earnings Call, May 08, 2024
09/05
Sonendo, Inc. Raises Revenue Guidance for the Full Year of 2024
09/05
CI
Sonendo, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
09/05
CI
Sonendo, Inc. Announces Sadie Stern Not to Stand for Reelection to the Board of Directors
11/04
CI
North American Morning Briefing : Stock Futures -2-
13/03
DJ
Transcript : Sonendo, Inc., Q4 2023 Earnings Call, Mar 11, 2024
12/03
Sonendo, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
12/03
CI
Sonendo, Inc. Provides Revenue Guidance for the First Quarter and Full Year of 2024
12/03
CI
Sonendo, Inc. Announces Impairment of Long-Lived Assets for the Three Months Ended December 31, 2023
12/03
CI
Sonendo, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
12/03
CI
Sonendo, Inc. Announces CFO Changes
09/03
CI
Sonendo, Inc. to Amend its Amended and Restated Credit Agreement and Guaranty with Perceptive Credit Holdings, LP
05/03
CI
Valsoft Corporation Inc. acquired TDO Software from Sonendo, Inc. for approximately $16 million.
04/03
CI
Sonendo, Inc. Announces Resignation of Karen Mcginnis as Director and Member of the Audit Committee and Compensation Committee, Effective March 31, 2024
14/02
CI
Sonendo, Inc. Partners with Best for Dentistry to Continue Expanding Access to the Innovative GentleWave Procedure
03/01
CI
Sonendo, Inc.(OTCPK:SONX) dropped from S&P TMI Index
28/11
CI
Sonendo, Inc. Primary Exchange Listing will Change to OTCQX Marketplace from New York Stock Exchange
22/11
CI
Sonendo Receives Suspension Notice From NYSE
22/11
MT
Sonendo, Inc. Announces Resignation of Michael Smith as Chief Commercial Officer Effective December 1, 2023
22/11
CI
Goldman Sachs Adjusts Sonendo's Price Target to $1.50 From $1.75, Maintains Buy Rating
09/11
MT
Morgan Stanley Adjusts Price Target on Sonendo to $4.60 From $5, Maintains Equal-Weight Rating
09/11
MT
Transcript : Sonendo, Inc., Q3 2023 Earnings Call, Nov 08, 2023
09/11
Earnings Flash (SONX) SONENDO Reports Q3 Revenue $10.4M, vs. Street Est of $10.4M
09/11
MT
Sonendo, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
09/11
CI
Sonendo Expects Q3 Revenue of $10.4 Million; Maintains 2023 Revenue Outlook
10/23/10
MT
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Sonendo, Inc. is a commercial-stage medical technology company focused on saving teeth from tooth decay. The Company develops and manufactures the GentleWave System, a technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The system utilizes a mechanism of action, which combines procedure fluid optimization, broad-spectrum acoustic energy, and advanced fluid dynamics, to debride and disinfect deep regions of the complex root canal system in a less invasive procedure that preserves tooth structure. Its Product segment includes the sales of the GentleWave System console and related accessories and instruments. The Company also offers ancillary products, such as SoundSeal and its Sonendo-branded liquid solution of ethylenediaminetetraacetic acid (EDTA). SoundSeal is a material used during the GentleWave Procedure to build and create a sealing platform on the top of the crown.
More about the company
Last Close Price
0.0902
USD
Average target price
0.25
USD
Spread / Average Target
+177.16%
Consensus
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
SONENDO, INC. 
